(Q41455673)

30 September 2017

title

Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague (English)

1 reference

30 September 2017

1

1 reference

30 September 2017

Mark J Martinez

2

1 reference

30 September 2017

language of work or name

English

0 references

publication date

9 December 2005

1 reference

30 September 2017

1 reference

30 September 2017

volume

24

1 reference

30 September 2017

issue

13

1 reference

30 September 2017

page(s)

2283-2289

1 reference

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

Yersinia pestis--etiologic agent of plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

Plague Immunization. V. Indirect Evidence for the Efficacy of Plague Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

Vaccination against bubonic and pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

A single dose sub-unit vaccine protects against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

Local and systemic immune response to a microencapsulated sub-unit vaccine for plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

Flow microsphere immunoassay for the quantitative and simultaneous detection of multiple soluble analytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

Yersinia pestis V protein epitopes recognized by CD4 T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

7 January 2021

Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

7 January 2021

Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

7 January 2021

Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

7 January 2021

Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.047

7 January 2021

10.1016/J.VACCINE.2005.11.047

Identifiers

DOI

1 reference

30 September 2017

1 reference